 |
| Raleigh NC (April
12, 2006) – Sicel Technologies, Inc., announced that DVS®
(Dose Verification System) , its wireless, implantable radiation sensor
and reader has received 510(k) clearance from the U.S. FDA. FDA clearance
was based upon successful completion of a multicenter clinical study
of breast cancer patients most of who were implanted with two DVS®
sensors prior to receiving radiation therapy. Using the hand held
reader, physicians were able to determine the actual dose of radiation
being delivered to the tumor after each course of therapy. Implantation
of the DVS® sensor did not lead to any adverse events in the clinical
trial.
DVS® is the first permanently implantable, wireless, telemetric, radiation sensor for human use to be commercially available in the United States. “We believe DVS® represents breakthrough technology that provides significant benefit both to the patient as well as to the oncologist treating the patient” said Michael Riddle President & CEO of Sicel Technologies, Inc. |
| Florida Cancer Centers Implement DVS |
| Download Sicel Technologies Official DVS SmartMarker Brochure |
| June 21, 2006 FDA Clears DVS for Prostate Cancer |
| April 12, 2006 DVS Receives 510K Clearance for Breast Cancer |
| First implantable radiation sensor receives clearance |
| An Analysis of an Implantable Dosimeter |
| Principles of Radiation Therapy |
